These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Synthesis and biological evaluation of pyridazinone derivatives as potential anti-inflammatory agents. Barberot C; Moniot A; Allart-Simon I; Malleret L; Yegorova T; Laronze-Cochard M; Bentaher A; Médebielle M; Bouillon JP; Hénon E; Sapi J; Velard F; Gérard S Eur J Med Chem; 2018 Feb; 146():139-146. PubMed ID: 29407945 [TBL] [Abstract][Full Text] [Related]
27. Phosphodiesterase inhibitors. Part 5: hybrid PDE3/4 inhibitors as dual bronchorelaxant/anti-inflammatory agents for inhaled administration. Ochiai K; Takita S; Kojima A; Eiraku T; Iwase K; Kishi T; Ohinata A; Yageta Y; Yasue T; Adams DR; Kohno Y Bioorg Med Chem Lett; 2013 Jan; 23(1):375-81. PubMed ID: 23200255 [TBL] [Abstract][Full Text] [Related]
28. Design and Synthesis of Novel Pyrazole-Substituted Different Nitrogenous Heterocyclic Ring Systems as Potential Anti-Inflammatory Agents. Nossier ES; Fahmy HH; Khalifa NM; El-Eraky WI; Baset MA Molecules; 2017 Mar; 22(4):. PubMed ID: 28338602 [TBL] [Abstract][Full Text] [Related]
29. Phosphodiesterase inhibitors. Part 2: design, synthesis, and structure-activity relationships of dual PDE3/4-inhibitory pyrazolo[1,5-a]pyridines with anti-inflammatory and bronchodilatory activity. Ochiai K; Ando N; Iwase K; Kishi T; Fukuchi K; Ohinata A; Zushi H; Yasue T; Adams DR; Kohno Y Bioorg Med Chem Lett; 2011 Sep; 21(18):5451-6. PubMed ID: 21764304 [TBL] [Abstract][Full Text] [Related]
30. Phosphodiesterase inhibitors. Part 6: design, synthesis, and structure-activity relationships of PDE4-inhibitory pyrazolo[1,5-a]pyridines with anti-inflammatory activity. Kojima A; Takita S; Sumiya T; Ochiai K; Iwase K; Kishi T; Ohinata A; Yageta Y; Yasue T; Kohno Y Bioorg Med Chem Lett; 2013 Oct; 23(19):5311-6. PubMed ID: 23988356 [TBL] [Abstract][Full Text] [Related]
31. Pyrazole derivatives as potent inhibitors of c-Jun N-terminal kinase: synthesis and SAR studies. Doma A; Kulkarni R; Palakodety R; Sastry GN; Sridhara J; Garlapati A Bioorg Med Chem; 2014 Nov; 22(21):6209-19. PubMed ID: 25261929 [TBL] [Abstract][Full Text] [Related]
32. Inhibition of neutrophil O(2)(-) production by unsymmetrical methylene derivatives of benzopyrans: their use as potential antiinflammatory agents. Mazzei M; Dondero R; Sottofattori E; Melloni E; Minafra R Eur J Med Chem; 2001; 36(11-12):851-61. PubMed ID: 11755228 [TBL] [Abstract][Full Text] [Related]
33. Construction of a six-membered fused N-heterocyclic ring via a new 3-component reaction: synthesis of (pyrazolo)pyrimidines/pyridines. Kumar PM; Kumar KS; Mohakhud PK; Mukkanti K; Kapavarapu R; Parsa KV; Pal M Chem Commun (Camb); 2012 Jan; 48(3):431-3. PubMed ID: 22075973 [TBL] [Abstract][Full Text] [Related]
34. Novel anti-inflammatory agents based on pyrazole based dimeric compounds; design, synthesis, docking and in vivo activity. Tewari AK; Srivastava P; Singh VP; Singh A; Goel RK; Mohan CG Chem Pharm Bull (Tokyo); 2010 May; 58(5):634-8. PubMed ID: 20460788 [TBL] [Abstract][Full Text] [Related]
35. The role of phosphodiesterase 4B in IL-8/LTB4-induced human neutrophil chemotaxis evaluated with a phosphodiesterase 4B inhibitor. Suzuki O; Goto T; Yoshino T; Nakamura S; Maeda H Acta Pharm; 2015 Jun; 65(2):191-7. PubMed ID: 26011935 [TBL] [Abstract][Full Text] [Related]
36. Synthesis and anti-inflammatory evaluation of new 1,3,5-triaryl-4,5-dihydro-1H-pyrazole derivatives possessing an aminosulphonyl pharmacophore. Abdellatif KR; Abdelgawad MA; Elshemy HA; Alsayed SS; Kamel G Arch Pharm Res; 2015 Nov; 38(11):1932-42. PubMed ID: 25904239 [TBL] [Abstract][Full Text] [Related]
37. Stereoselective synthesis of novel pyrazole derivatives using tert-butansulfonamide as a chiral auxiliary. Park CM; Jeon DJ Org Biomol Chem; 2012 Apr; 10(13):2613-20. PubMed ID: 22371117 [TBL] [Abstract][Full Text] [Related]
38. Synthesis of Asymmetric 1-Thiocarbamoyl Pyrazoles as Potent Anti- Colon Cancer, Antioxidant and Anti-Inflammatory Agent. Raut DG; Patil SB; Kadu VD; Hublikar MG; Bhosale RB Anticancer Agents Med Chem; 2018; 18(15):2117-2123. PubMed ID: 30417799 [TBL] [Abstract][Full Text] [Related]
39. Synthesis of novel 3,5-diaryl pyrazole derivatives using combinatorial chemistry as inhibitors of tyrosinase as well as potent anticancer, anti-inflammatory agents. Bandgar BP; Totre JV; Gawande SS; Khobragade CN; Warangkar SC; Kadam PD Bioorg Med Chem; 2010 Aug; 18(16):6149-55. PubMed ID: 20638287 [TBL] [Abstract][Full Text] [Related]
40. Diastereoselective synthesis and profiling of bicyclic imidazolidinone derivatives bearing a difluoromethylated catechol unit as potent phosphodiesterase 4 inhibitors. Dorokhov VS; Golovanov IS; Tartakovsky VA; Sukhorukov AY; Ioffe SL Org Biomol Chem; 2018 Oct; 16(38):6900-6908. PubMed ID: 30024008 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]